Moshe Arkin

Arkin Communications Ltd. is an investment holding Israeli company. The private company is based in Herzliya, Israel.

HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel.

N.L.T Spine Ltd. develops spine surgery instrumentation and implants for treating degenerative spinal conditions. Its products include PROW FUSION and eSPIN System. The company was founded in 2006 by Didier Toubia and Tzony Siegal and is headquartered in Kfar Saba, Israel.

Meridian Bioscience Israel Ltd. engages in the development, manufacturing, marketing, and distribution of diagnostic and life science products. It offers its solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies. The company was founded by Uri Geiger on April 11, 2006 and is headquartered in Modi'in-Maccabim-Re'ut, Israel.

A.M. Accelmed Management (2009) Ltd (Accelmed) is a private equity subsidiary of Arkin Moshe founded in 2009. The firm is headquartered in Miami, Florida.

cCAM Biotherapeutics Ltd. is a preclinical-stage company engaging in the development of immunotherapies to treat cancer. The company was founded by Silvia Noiman and Gal Markel in 2010 and is headquartered in Hod Ha'Sharon, Israel.

Quiet Therapeutics Ltd. develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs. It developed a class of cancer therapeutics called GAGomers, enables the flexibility of delivering a medicine that can kill the cancer cells and block the production of proteins that promote the cancer. The company was founded by Dan Peer and Rimona Margalit in 2009 and is headquartered in Ness Ziona, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

NanoDoc Biotechnology Ltd. develops treatment for diseases such as cancer. The company is headquartered in Rehovot, Israel.

Digma Medical Ltd. develops a device-based, one-time, non-invasive procedure, that restores the body’s natural ability to control glucose, which may provide long term remission from Type-2 Diabetes. The company was founded by Tamir Wolf and Irit Yaniv in 2013 and is headquartered in Petah Tikva, Israel.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

Arkin Bio Ventures (Arkin Bio) is a venture capital arm of Arkin Holdings founded in 2016. The firm is headquartered in Tel Aviv, Israel.

ValCare Medical, Inc. engages in the designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve diseases. The firm develops a unique transcatheter device, which will provide the capability to implant the mitral annuloplasty device interventionally without surgery. The company was founded by Samuel M. Shaolian in 2012 and is headquartered in Herzlyia Pituach, Israel.